|
|
|
Insider
Information: |
Schuth Alexander O. |
Relationship: |
COFO and Secretary |
City: |
South San Francisco |
State: |
CA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
1 |
|
Direct
Shares |
187,341 |
|
Indirect Shares
|
523,749 |
|
|
Direct
Value |
$3,862,971 |
|
|
Indirect Value
|
$10,799,704 |
|
|
Total
Shares |
711,090 |
|
|
Total
Value |
$14,662,676 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
15
|
Stock
price went up :
|
0
|
2
|
Stock
price went down : |
0
|
13
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
0.0%
|
-30.3%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Denali Therapeutics Inc. |
DNLI |
COFO and Secretary |
2024-02-14 |
187,341 |
2024-02-14 |
523,749 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 1 of 1
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
DNLI |
Denali Therapeutics Inc. |
COO and Secretary |
|
2020-03-30 |
4 |
S |
$19.49 |
$27,812 |
D/D |
(1,427) |
28,662 |
0 |
% |
|
DNLI |
Denali Therapeutics Inc. |
COO and Secretary |
|
2021-02-09 |
4 |
S |
$74.66 |
$109,809 |
I/I |
(1,468) |
537,344 |
0 |
% |
|
DNLI |
Denali Therapeutics Inc. |
COO and Secretary |
|
2021-02-11 |
4 |
S |
$70.17 |
$214,341 |
I/I |
(3,047) |
541,582 |
0 |
% |
|
DNLI |
Denali Therapeutics Inc. |
COO and Secretary |
|
2021-08-19 |
4 |
S |
$49.56 |
$126,186 |
I/I |
(2,544) |
484,038 |
0 |
% |
|
DNLI |
Denali Therapeutics Inc. |
COO and Secretary |
|
2022-01-05 |
4 |
S |
$44.77 |
$127,415 |
I/I |
(2,846) |
457,737 |
0 |
% |
|
DNLI |
Denali Therapeutics Inc. |
COO and Secretary |
|
2022-02-09 |
4 |
S |
$37.10 |
$52,800 |
I/I |
(1,423) |
460,564 |
0 |
% |
|
DNLI |
Denali Therapeutics Inc. |
COO and Secretary |
|
2022-02-11 |
4 |
S |
$34.68 |
$97,208 |
I/I |
(2,803) |
465,047 |
0 |
% |
|
DNLI |
Denali Therapeutics Inc. |
COFO and Secretary |
|
2022-08-19 |
4 |
S |
$33.22 |
$85,575 |
I/I |
(2,576) |
467,471 |
0 |
% |
|
DNLI |
Denali Therapeutics Inc. |
COFO and Secretary |
|
2023-01-04 |
4 |
S |
$28.70 |
$83,574 |
D/D |
(2,912) |
149,828 |
0 |
% |
|
DNLI |
Denali Therapeutics Inc. |
COFO and Secretary |
|
2023-01-04 |
4/A |
S |
$28.70 |
$83,574 |
I/I |
(2,912) |
492,309 |
0 |
- |
|
DNLI |
Denali Therapeutics Inc. |
COFO and Secretary |
|
2023-01-05 |
4 |
S |
$28.44 |
$74,968 |
I/I |
(2,636) |
497,173 |
0 |
% |
|
DNLI |
Denali Therapeutics Inc. |
COFO and Secretary |
|
2023-02-08 |
4 |
S |
$30.89 |
$46,984 |
I/I |
(1,521) |
499,902 |
0 |
% |
|
DNLI |
Denali Therapeutics Inc. |
COFO and Secretary |
|
2023-02-13 |
4 |
S |
$30.09 |
$105,225 |
I/I |
(3,497) |
528,691 |
0 |
% |
|
DNLI |
Denali Therapeutics Inc. |
COFO and Secretary |
|
2023-08-10 |
4 |
S |
$24.18 |
$68,986 |
I/I |
(2,853) |
521,761 |
0 |
% |
|
DNLI |
Denali Therapeutics Inc. |
COFO and Secretary |
|
2023-08-21 |
4 |
S |
$22.59 |
$55,978 |
I/I |
(2,478) |
521,511 |
0 |
% |
|
DNLI |
Denali Therapeutics Inc. |
COFO and Secretary |
|
2024-01-05 |
4 |
S |
$19.43 |
$193,756 |
I/I |
(9,972) |
539,307 |
0 |
% |
|
DNLI |
Denali Therapeutics Inc. |
COO and Secretary |
|
2018-06-22 |
4 |
OE |
$5.28 |
$31,247 |
D/D |
5,918 |
5,918 |
0 |
- |
|
DNLI |
Denali Therapeutics Inc. |
COO and Secretary |
|
2018-10-02 |
4 |
OE |
$5.28 |
$62,498 |
D/D |
7,043 |
12,961 |
0 |
- |
|
DNLI |
Denali Therapeutics Inc. |
COO and Secretary |
|
2019-08-20 |
4 |
OE |
$0.00 |
$0 |
D/D |
5,643 |
22,685 |
0 |
- |
|
DNLI |
Denali Therapeutics Inc. |
COO and Secretary |
|
2019-10-23 |
4 |
OE |
$5.28 |
$27,081 |
D/D |
5,129 |
25,839 |
0 |
- |
|
DNLI |
Denali Therapeutics Inc. |
COO and Secretary |
|
2019-12-03 |
4 |
OE |
$5.28 |
$3,754 |
D/D |
711 |
26,550 |
0 |
- |
|
DNLI |
Denali Therapeutics Inc. |
COO and Secretary |
|
2019-12-04 |
4 |
OE |
$5.28 |
$16,479 |
D/D |
3,121 |
28,960 |
0 |
- |
|
DNLI |
Denali Therapeutics Inc. |
COO and Secretary |
|
2020-02-07 |
4/A |
OE |
$0.00 |
$0 |
D/D |
4,250 |
30,089 |
0 |
- |
|
DNLI |
Denali Therapeutics Inc. |
COO and Secretary |
|
2020-08-20 |
4 |
OE |
$0.00 |
$0 |
I/I |
5,643 |
616,516 |
0 |
- |
|
DNLI |
Denali Therapeutics Inc. |
COO and Secretary |
|
2021-02-07 |
4 |
OE |
$0.00 |
$0 |
I/I |
4,250 |
538,812 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|